2 Top Growth Stocks to Buy in January

Dye & Durham (TSX:DND) and Tecsys (TSX:TCS) are two top growth stocks to buy during the first month of 2022.

| More on:

If you want to start 2022 on the right foot financially, Dye & Durham (TSX:DND) and Tecsys (TSX:TCS) are two growth stocks that should perform well in January.

Dye & Durham

Dye & Durham provides cloud-based information services and workflow solutions to legal, government, and financial services firms. The company’s strategy is to grow through acquisitions that immediately generate profits.

As Dye & Durham works in a niche market, it doesn’t worry about too much competition. The company also showed strength when it rejected a takeover bid to privatize the company. Dye & Durham continued with its existing business strategy of growth through acquisitions as it believes this strategy can deliver shareholder value. The efficient execution of all acquisitions by the company makes it one of the best growth stocks to buy and hold forever.

The company posted better-than-expected results for the first fiscal quarter of 2022. Revenue and adjusted EBITDA increased 414% and 398%, respectively, with net income of $22.1 million. The strong results underscore the breadth and pace of Dye & Durham’s underlying growth.

Dye & Durham has signed an agreement to purchase Telus Financial Solutions for $500 million. This acquisition should go a long way in strengthening its digital infrastructure.

The company also signed a deal to acquire Link Group, a technology-driven market leader that connects people to their assets for $3.2 billion. The acquisition confirms the company’s ambition to achieve $1 billion in adjusted EBITDA.

Its diverse customer base, high retention rate, geographic expansion and long-term contracts with top clients will support its growth. In addition, its strong M&A pipeline and strong balance sheet will likely accelerate its rate of growth.

Tecsys

Another growth stock that deserves a mention is Tecsys. Tecsys develops and sells end-to-end supply chain management software solutions. Thus, the company is right in the “sweet spot” with all of the current supply chain issues.

Its main clients are health networks in the United States a vertical that it dominates. It also serves businesses with complex distribution needs, like wholesaling and transportation logistics, as well as retailers with omnichannel sales.

The company just reported another quarter of record sales with high-margin SaaS recurring revenue growth and has a record backlog.

Tecsys had its 11th consecutive quarter of record revenue at $34.3 million, up 12% year over year. SaaS revenue increased 28% to $6.6 million, while subscription bookings was up 50% to $4 million. Professional services revenue was up 11% to $13.1 million.

Peter Brereton, president and CEO, said in a press release: “Our three target verticals are all performing or outperforming expectations, with notable wins in healthcare with three new major hospital networks, and an expanding customer base in global retail and our distribution market. We are confident that we are favourably positioned as the heightened focus on supply chains turns into greater investment in supply chain agility and the specialized technologies that underpin it.”

The company just reported another quarter of record results and record backlog, and the pullback represents a tremendous buying opportunity

Tecsys has been included in the TSX30 for 2021, which recognizes the 30 top-performing stocks over the past three years. 

Tecsys’ dividend yield of around 0.5% is low, but it’s a Canadian Dividend Aristocrat. Specifically, the growth stock has increased its dividend for 13 consecutive years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool owns and recommends Tecsys Inc.

More on Tech Stocks

Rocket lift off through the clouds
Tech Stocks

TFSA Investors: 1 Top Stock Primed for Performance

Here's why I think Constellation Software (TSX:CSU) is a top growth stock that could outperform in the years to come.

Read more »

AI microchip
Tech Stocks

1 Stock That’s Just as Hot as NVIDIA (Without All the Hype)

Taiwan Semiconductor (NYSE:TSM) is doing big things in computer chips. Canadian companies like POET Technologies (TSXV:POET) are too.

Read more »

Rocket lift off through the clouds
Dividend Stocks

3 TSX Stocks Ready to Explode in Value

These stocks in rate-sensitive sectors could seriously break out after the rate cut.

Read more »

telehealth stocks
Tech Stocks

2 Growth Stocks That are Screaming Buys in October

As interest rates continue to decline, these two undervalued growth stocks are some of the best investments you can buy…

Read more »

RRSP Canadian Registered Retirement Savings Plan concept
Dividend Stocks

Retirement Planning: 2 RRSP Stocks for a Bigger Nest Egg

Choosing the right buy-and-forget stocks for your RRSP can enormously impact the growth rate and final size of your final…

Read more »

Man holds Canadian dollars in differing amounts
Tech Stocks

2 Incredibly Cheap Tech Stocks to Buy Now

Kraken Robotics and Vecima Networks are two undervalued TSX tech stocks that should be part of your equity watchlist in…

Read more »

Piggy bank with word TFSA for tax-free savings accounts.
Tech Stocks

TFSA: 3 Top Stocks for Your $7,000 Contribution

The Tax-Free Savings Account can be used to hold a diversified portfolio of quality TSX stocks such as Shopify and…

Read more »

space ship model takes off
Tech Stocks

2 Growth Stocks That Could Skyrocket in 2025 and Beyond

Here's why growth stocks such as Lumine and MDA Group are positioned to deliver outsized gains to shareholders in 2024…

Read more »